Myrtol

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Essential oil of the myrtle bush, mucolytic, expectorant.

Field of application/use
This section has been translated automatically.

Expectoration promotion in bronchopulmonary diseases.

Limited indication
This section has been translated automatically.

Cholelithiasis, nephrolithiasis.

Dosage
This section has been translated automatically.

3-4 times/day 240-300 mg p.o., later 3 times 120-240 mg/day

Undesirable effects
This section has been translated automatically.

Allergic reactions, gastrointestinal disturbances.

Trade names
This section has been translated automatically.

Gelomyrtol®

Literature
This section has been translated automatically.

  1. Gillissen A et al(2013) A multi-centre, randomised, double-blind, placebo-cotrolled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis. Drug Res (Stuttgart) 63:19-27.
  2. Grassmann J et al.(2000) Antioxidant properties of essential oils. Possible explanations for their anti-inflammatory effects. Drug research 50:135-139.
  3. Koch AK et al.,(2016) A Systematic Review of Phytotherapy for Acute Rhinosinusitis. Research Komplementmed 23:165-169.
  4. Rantzsch U et al.(2009) Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease. Eur J Med Res 14 Suppl 4:205-209.

Incoming links (2)

Aromatics; Decongestives;

Outgoing links (1)

Myrtle;